Xinyi Zhang

Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis

Weifang Zhang, Tiantian Zhu, Xiaoyue Ge, 2020, Respiratory Research.

The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non‐small cell lung cancer: A meta‐analysis of randomized controlled trials

Nachuan Luo, Yiping Wei, Wenxiong Zhang, 2021, Journal of clinical pharmacy and therapeutics.

Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy

Weifang Zhang, Tiantian Zhu, Xinyi Zhang, 2020, Journal of Nanobiotechnology.

SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma

Weifang Zhang, Shan-Bu Xie, Xinyi Zhang, 2019, Oncology letters.

Role of YAP in lung cancer resistance to cisplatin.

F. Xiong, Xiaoqun Ye, Juan Song, 2018, Oncology letters.

Two cycles versus three cycles of neoadjuvant sintilimab plus platinum-doublet chemotherapy in patients with resectable non-small-cell lung cancer (neoSCORE): A randomized, single center, two-arm phase II trial.

F. Qiu, Yunke Wang, Yunben Yang, 2022, Journal of Clinical Oncology.

Systematic Analysis of Stress Granule Regulators-Associated Molecular Subtypes Predicts Drug Response, Immune Response, and Prognosis in Non-Small Cell Lung Cancer

Dan Wang, Xinyi Zhang, Youwen Xiong, 2022, Frontiers in Cell and Developmental Biology.

Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon

Xinyi Zhang, Delong Chen, Yuxuan Zhang, 2021, Frontiers in Cardiovascular Medicine.